[go: up one dir, main page]

WO2004047795A3 - Application cutanee de flupirtine - Google Patents

Application cutanee de flupirtine Download PDF

Info

Publication number
WO2004047795A3
WO2004047795A3 PCT/EP2003/012875 EP0312875W WO2004047795A3 WO 2004047795 A3 WO2004047795 A3 WO 2004047795A3 EP 0312875 W EP0312875 W EP 0312875W WO 2004047795 A3 WO2004047795 A3 WO 2004047795A3
Authority
WO
WIPO (PCT)
Prior art keywords
flupirtine
cutaneous application
cutaneous
application
cutaneously
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/012875
Other languages
German (de)
English (en)
Other versions
WO2004047795A2 (fr
Inventor
Dirk Mertin
Gerald Beddies
Sabine Becker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Priority to AU2003289876A priority Critical patent/AU2003289876A1/en
Publication of WO2004047795A2 publication Critical patent/WO2004047795A2/fr
Publication of WO2004047795A3 publication Critical patent/WO2004047795A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un médicament pour l'application cutanée de flupirtine ou de ses sels.
PCT/EP2003/012875 2002-11-28 2003-11-18 Application cutanee de flupirtine Ceased WO2004047795A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003289876A AU2003289876A1 (en) 2002-11-28 2003-11-18 Cutaneous application of flupirtine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255415.3 2002-11-28
DE10255415A DE10255415A1 (de) 2002-11-28 2002-11-28 Dermale Applikation von Flupirtin

Publications (2)

Publication Number Publication Date
WO2004047795A2 WO2004047795A2 (fr) 2004-06-10
WO2004047795A3 true WO2004047795A3 (fr) 2004-09-10

Family

ID=32308774

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/012875 Ceased WO2004047795A2 (fr) 2002-11-28 2003-11-18 Application cutanee de flupirtine

Country Status (3)

Country Link
AU (1) AU2003289876A1 (fr)
DE (1) DE10255415A1 (fr)
WO (1) WO2004047795A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102007034976A1 (de) * 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601195A1 (de) * 1985-01-23 1986-07-24 Degussa Ag, 6000 Frankfurt Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika
US5162346A (en) * 1990-07-14 1992-11-10 Asta Medica Aktiengesellschaft Pharmaceutical composition comprising flupirtine and its use to combat muscular tension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601195A1 (de) * 1985-01-23 1986-07-24 Degussa Ag, 6000 Frankfurt Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika
US5162346A (en) * 1990-07-14 1992-11-10 Asta Medica Aktiengesellschaft Pharmaceutical composition comprising flupirtine and its use to combat muscular tension
US5284861A (en) * 1990-07-14 1994-02-08 Asta Medica Ag Pharmaceutical composition comprising flupirtine and its use to combat Parkinson disorders
EP0659410B1 (fr) * 1990-07-14 2001-10-17 ASTA Medica Aktiengesellschaft Utilisation du composé flupirtin pour la préparation d'un medicament pour lutter contre la raideur musculaire

Also Published As

Publication number Publication date
AU2003289876A8 (en) 2004-06-18
AU2003289876A1 (en) 2004-06-18
DE10255415A1 (de) 2004-06-09
WO2004047795A2 (fr) 2004-06-10

Similar Documents

Publication Publication Date Title
WO2003080582A3 (fr) Derives de fredericamycine
AU2002353170A1 (en) Lens-focused ultrasonic applicator for medical applications
AU2003248245A1 (en) Remedies for diseases caused by vascular contraction or dilation
DK1344893T3 (da) Aktuator med konstant kraft
AU2002357323A1 (en) Self-cooled ultrasonic applicator for medical applications
WO2006122186A3 (fr) Derives de 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone utilises dans le traitement de l'hypercholesterolemie
AU2003302238A1 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003278406A1 (en) Amorphous form of esomeprazole salts
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
WO2005105110A3 (fr) Analogues de doxepine et leurs procedes d'utilisation
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
IL182834A0 (en) Sulfonamido-macrocycles and the salts thereof, a pharmaceutical composition comprisng these compounds, the method of preparing and the use thereof
AU2003276054A1 (en) Method for the production of powdered active substance formulations by means of compressible fluids
WO2003037863A3 (fr) Indoles substitues, procede pour leur preparation et leur utilisation pour lutter contre la douleur
BR0315375B1 (pt) processo para a preparaÇço conjunta de compostos.
AU2003233820A1 (en) Method for the treatment of starch
AU2003244181A1 (en) Phenoxypyridine derivative or salt thereof
WO2004092481A3 (fr) Procede de traitement de surfaces de papier
WO2004047795A3 (fr) Application cutanee de flupirtine
AU2003220567A1 (en) Compostions for darkening the skin
AU2003264406A1 (en) Drug or cosmetic
AU2003241400A1 (en) Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003236039A1 (en) Preventives/remedies for hotflash

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP